Skip to content

Dual druggable genome siRNA and compound screening approaches identify novel modulators of parkin recruitment to mitochondria

Research output: Contribution to journalArticle (Academic Journal)

Original languageEnglish
JournalJournal of Biological Chemistry
DateSubmitted - 1 Oct 2019
DateAccepted/In press - 7 Jan 2020
DatePublished (current) - 7 Jan 2020


Genetic and biochemical evidence points to an association between mitochondrial dysfunction and Parkinson’s disease (PD). PD-associated mutations in several genes have been identified and include those encoding PTEN-induced putative kinase 1 (PINK1) and parkin. To identify genes, pathways, and pharmacological targets that modulate the clearance of damaged or old mitochondria (mitophagy), here we developed a high-content imaging-based assay of parkin recruitment to mitochondria and screened both a druggable genome-wide siRNA library and a small neuroactive compound library. We used a multi-parameter principal component analysis and an unbiased parameter-agnostic machine-learning approach to analyze the siRNA-based screening data. The hits identified in this analysis included specific genes of the ubiquitin proteasome system, and inhibition of ubiquitin-conjugating enzyme 2 N (UBE2N) with a specific antagonist, Bay 11-7082, indicated that UBE2N modulates parkin recruitment and downstream events in the mitophagy pathway. Screening of the compound library identified kenpaullone, an inhibitor of cyclin-dependent kinases (CDKs) and glycogen synthase kinase 3 (GSK3), as a modulator of parkin recruitment. Validation studies revealed that kenpaullone augments the mitochondrial network and protects against the complex I inhibitor MPP+. Finally, we used a microfluidics platform to assess the timing of parkin recruitment to depolarized mitochondria and its modulation by kenpaullone in real time and with single-cell resolution. We demonstrate that the high-content imaging-based assay presented here is suitable for both genetic and pharmacological screening approaches, and we also provide evidence that pharmacological compounds modulate PINK1-dependent parkin recruitment.

    Research areas

  • mitochondria, parkin, ubiquitin, mitophagy, Parkinson’s, kenpaullone

Download statistics

No data available



  • Full-text PDF (final published version)

    Rights statement: This is the final published version of the article (version of record). It first appeared online via ASBMB Publications at Please refer to any applicable terms of use of the publisher.

    Final published version, 3.28 MB, PDF document

    Licence: CC BY


View research connections

Related faculties, schools or groups